Comparison of the Effects of Intralipid 10% and 20% on Peripheral Catheter Ablation in a Pediatric Intensive Care Unit

Document Type: Original Article


1 Department of Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran

2 Fellowship of Pediatric Intensive Care, Pediatric Intensive Care Unit, Dr. Sheikh Pediatric Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Associate Professor, Department of Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran

4 Assistant Professor, Pediatric Intensive Care Unit, Dr. Sheikh Pediatric Hospital, Mashhad University of Medical Sciences, Mashhad, Iran


Background: Energy deficit is a common and serious problem in pediatric intensive care units. Parenteral nutrition, either alone or in combination with enteral nutrition, can improve nutrient delivery in critically ill patients by preventing or correcting the energy deficit and improving the outcomes. Intralipid 10% and 20% are lipid emulsions, widely used in parenteral nutrition. Despite several clinical advantages, intravenous Intralipid therapy has been associated with several complications.In this study, we aimed to investigate the effects of Intralipid 10% and 20% on peripheral intravenous catheter ablation in children receiving Intralipid in a pediatric intensive care unit.
Methods: In this observational study, 96 patients were recruited through simple non-random sampling over six months. In total, 48 patients received intravenous Intralipid 10%, while 48 patients were administered Intralipid 20% as part of their parenteral nutrition plan. Through separate peripheral intravenous catheters, 0.5-3 g/kg/day of Intralipid was administered at an infusion rate of 0.5 g/kg/h. Length of hospital stay and intravenous catheter ablation were compared between the two groups.
Results: Age of the patients ranged between two days and eight years. Esophageal atresia was the most common condition among patients receiving intravenous Intralipid infusion (8.3%). The mean duration of catheter survival was significantly shorter in patients receiving Intralipid 20% (28.77 vs. 68.23 h, P<0.001), while length of hospital stay was not significantly different between the two groups (P=0.48).

Conclusion: Based on the findings, concentration of Intralipid infusion in pediatric patients, receiving parenteral nutrition, might be associated with intravenous catheter ablation.


  1. Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010; 36(5):735-49.
  2. Chan S, McCowen KC, Blackburn GL. Nutrition management in the ICU. Chest. 1999; 115(5 Suppl):145S-8.
  3. Huang YC, Yen CE, Cheng CH, Jih KS, Kan MN. Nutritional status of mechanically ventilated critically ill patients: comparison of different types of nutritional support. Clin Nutr. 2000; 19(2):101-7.
  4. Skeie B, Askanazi J, Rothkopf MM, Rosenbaum SH, Kvetan V, Thomashow B. Intravenous fat emulsions and lung function: a review. Crit Care Med. 1988; 16(2):183-94.
  5. Puntis JW, Rushton DI. Pulmonary intravascular lipid in neonatal necropsy specimens. Arch Dis Child. 1991; 66(1 Spec No):26-8.
  6. Tashiro T, Mashima Y, Yamamori H, Sanada M, Nishizawa M, Okui K. Intravenous intralipid 10% vs. 20%, hyperlipidemia, and increase in lipoprotein X in humans. Nutrition. 1992; 8(3):155-60.
  7. Barrington KJ, Chan G, Aerde JE. Intravenous lipid composition affects hypoxic pulmonary vasoconstriction in the newborn piglet. Can J Physiol Pharmacol. 2001; 79(7):594-600.
  8. Brans YW, Dutton EB, Andrew DS, Menchaca EM, West DL. Fat emulsion tolerance in very low birth weight neonates: effect on diffusion of oxygen in the lungs and on blood pH. Pediatrics. 1986; 78(1):79-84.
  9. Cooke RW. Factors associated with chronic lung disease in preterm infants. Arch Dis Child. 1991; 66(7 Spec No):776-9.
10. Paolisso G, Manzella D, Rizzo MR, Ragno E, Barbieri M, Varricchio G, et al. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr. 2000; 72(3):723-30.

11. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995; 25(4 Pt 2):774-8.

12. Pitkanen O, Hallman M, Andersson S. Generation of free radicals in lipid emulsion used in parenteral nutrition. Pediatr Res. 1991; 29(1):56-9.

13. Haastrup A, Gadegbeku CA, Zhang D, Mukhin YV, Greene EL, Jaffa AA, et al. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001; 38(4):858-63.

14. Stepniakowski KT, Lu G, Davda RK, Egan BM. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension. 1997; 30(6):1634-9.

15. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C–independent mechanism. Hypertension. 1995; 26(5):764-70.

16. Embleton ND, Simmer K. Practice of parenteral nutrition in VLBW and ELBW infants. World Rev Nutr Diet. 2014; 110:177-89

  1. 17.  Vivanco Allende A, Rey Galán C, Rodríguez de la Rúa MV, Alvarez García F, Medina Villanueva A, Concha Torre A, et al. [Thrombosis and obstruction associated with central venous lines. Incidence and risk factors]. An Pediatr (Barc). 2013; 79(3):136-41.
18. Teng J, Arnell H, Bohlin K, Nemeth A, Fischler B. Impact of Parenteral Fat Composition on cholestasis in Preterm Infants. J Pediatr Gastroenterol Nutr. 2015; 60(6):702-7.